- Report
- July 2023
- 108 Pages
Global
From €3500EUR$3,933USD£3,088GBP
- Report
- February 2022
- 86 Pages
Global
From €3200EUR$3,596USD£2,823GBP
- Report
- July 2021
- 123 Pages
Global
From €3200EUR$3,596USD£2,823GBP
- Report
- October 2022
- 57 Pages
Global
From €3337EUR$3,500USD£2,844GBP
- Report
- May 2022
- 59 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Drug Pipelines
- June 2021
- 789 Pages
Global
From €2383EUR$2,500USD£2,031GBP
- Drug Pipelines
- March 2021
Global
From €1907EUR$2,000USD£1,625GBP
- Drug Pipelines
- August 2019
- 50 Pages
Global
From €3337EUR$3,500USD£2,844GBP
- Drug Pipelines
- August 2018
- 55 Pages
Global
From €3337EUR$3,500USD£2,844GBP
- Report
- February 2024
- 132 Pages
Global
From €906EUR$950USD£772GBP
- Report
- February 2024
- 132 Pages
Global
From €906EUR$950USD£772GBP
- Report
- November 2021
- 844 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- April 2023
- 290 Pages
Global
From €3403EUR$3,570USD£2,901GBP
- Report
- April 2023
- 147 Pages
Global
From €5719EUR$5,999USD£4,875GBP
- Report
- March 2022
- 149 Pages
Global
From €4290EUR$4,500USD£3,657GBP
- Report
- January 2022
- 137 Pages
Global
From €4290EUR$4,500USD£3,657GBP
- Book
- July 2009
- 1116 Pages
The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates.
Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more